Developer docs
API playgroundTry for free, no card

Search company profiles

acCELLerate

Full company profile

uuid000l3wl

Namestring
acCELLerate
Legal namestring
acCELLerate GmbH
Websiteurl
accellerate.me
Company typeenum
Private
Founded yearint
2000
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHamburg, Germany
HQ citystring
Hamburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
assay ready cells, custom cell banking, in vitro bioassays, GMP potency assays, cryopreserved cell reagents
Industry3 codes
PRIMARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAFAJ
In Vitro Toxicology (Cell-based/Organ-on-chip)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAAABAK
Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Biotech Reagents
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Custom Cell Banking Services
TypeOne Time License
Description

Custom cell banking projects including Master Cell Banks (MCB), Working Cell Banks (WCB), and assay-ready instaCELLs. Projects include cell line transfer, cultivation and freezing process implementation, and preparation of starting cell banks. Batch sizes range from 50 to 1,000 vials with custom aliquots from 1 million to 100 million cells.

accellerate.me
2instaCELL Assay Kits
TypeOne Time License
Description

Pre-packaged kits combining assay-ready instaCELLs, plates, media, reagents, and controls with validated protocols. Includes cytotoxicity, skin sensitization, genotoxicity, pyrogen detection, and bioassay kits.

accellerate.me
3Premium GMP Documentation Service
TypeProfessional Services
Description

Comprehensive GMP-compliant documentation for analytical cell banks used in GMP-bioassays. Includes manufacturing batch records, quality reports with certificate of analysis (CoA), and certificate of conformity (CoC).

accellerate.me
4Cell Storage Services
TypeSubscription Recurring
Description

Custom storage for cell banks under properly controlled conditions with on-demand delivery and automatic replenishment of assay-ready instaCELLs.

accellerate.me
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Custom cell banking projects are quote-based
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing based on project requirements including cell line, aliquot size, batch size, and service level (standard vs premium GMP documentation).

accellerate.me
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1instaCELL
Description

Assay-ready frozen cells that can be used directly in assays without prior cultivation, essentially functioning as a reagent. Available in kit format for various testing applications including cytotoxicity, biocompatibility, skin sensitization, genotoxicity, and pyrogen detection.

accellerate.me
Core offering1 text field

acCELLerate produces and cryopreserves assay-ready cells (branded as instaCELLs) that can be used directly in cell-based assays without prior cultivation, functioning as consumable reagents. The company offers custom cell banking services (Master Cell Banks, Working Cell Banks, and large homogeneous assay-ready banks) for pharmaceutical and biotechnology clients, along with a portfolio of pre-validated assay kits for safety testing (cytotoxicity, skin sensitization, genotoxicity, pyrogen detection) and bioassay potency testing (TNF-α, G-CSF, GM-CSF, IL-2). It also supplies recombinant Assay Ready Cells (ARC) from partner AssayWorks for compound screening and lead identification.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Improved assay precision through exclusion of cell culture variability
Product overview1 text field

acCELLerate offers a portfolio of assay-ready cell products and custom cell banking services centered around their proprietary instaCELL technology. The core offering includes a comprehensive range of validated assay kits for safety testing (cytotoxicity, genotoxicity, skin sensitization, pyrogen detection) and bioassay potency testing (TNF-alpha, G-CSF, GM-CSF, IL-2), all featuring ready-to-use frozen cells that eliminate cell culture variability. Custom cell banking services provide Master Cell Banks (MCB), Working Cell Banks (WCB), and large homogeneous banks of assay-ready instaCELLs for pharmaceutical and biotechnology research. The ARC (Assay Ready Cells) line offers recombinant cell lines expressing receptors and ion channels for drug discovery screening applications. The company pioneered the assay-ready approach in Europe in the early 2000s and works with over 1,500 different cell lines.

Product and service1 record
1instaCELL Cytotoxicity Assay Kit
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-10
Description

acCELLerate has established a partnership with ATCC to produce custom cell banks from ATCC's authenticated cell lines for research clients in pharmaceutical and biotechnology sectors. The collaboration aims to enhance assay reproducibility and scalability for research and development of new pharmaceuticals.

2AssayWorks
Strategic tierCoreTypeTechnology or Integration
Description

AssayWorks, Germany developed recombinant cell lines expressing pharmaceutically relevant receptors and ion channels. acCELLerate provides these cell lines in assay ready format for compound screening, lead identification, and selectivity testing.

accellerate.me
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global biological resource provider offering authenticated cell lines and related services. Direct comparable in cell-line supply and custom cell banking, and is also a strategic partner of acCELLerate for authenticated lines.

TypeBroad incumbent
Description

Supplies proteins, antibodies, and cell-based assay reagents including GMP-grade cytokines and cell culture tools. Overlaps with acCELLerate on the reagent side of potency and bioassay workflows.

TypeBroad incumbent
Description

Through HemaCare, supplies fresh and cryopreserved primary blood cells for research and cell therapy. Competes in the same cryopreserved-cell-for-assays market with the backing of a much larger CRO.

TypeBroad incumbent
Description

Through CellGenix, supplies GMP-grade raw materials and cell-based assay reagents for cell and gene therapy manufacturing. Comparable in the GMP bioassay and ATMP/QC tooling space, though at much larger scale.

TypeDirect peer
Description

Specializes in cryopreserved PBMCs and immune cell-based assay services (ELISpot, FluoroSpot). Comparable niche player focused on cryopreserved cells as reproducible assay inputs for immunology research.

TypeDirect peer
Description

German provider of primary human cells, cell culture media, and cell-based assays. Closely comparable to acCELLerate in geography, target customer (pharma/cosmetics/medical device testing labs), and product portfolio.

7Cellero (BioLife Solutions)
TypeDirect peer
Description

Supplies cryopreserved primary immune cells (PBMCs, NK cells, T cells) and related products for cell-based assays and cell therapy research. Highly comparable use case: turning cryopreserved cells into off-the-shelf assay reagents.

TypeBroad incumbent
Description

Through its Gibco brand, supplies cell culture media, primary cells, and cell lines used in bioassays. Competes with acCELLerate across cell-based reagents and custom cell services, with much broader catalog and global reach.

TypeBroad incumbent
Description

Global cell and gene therapy CDMO with a large cell biology products portfolio. Overlaps with acCELLerate in custom cell banking and cell-based assay reagents, but at far greater scale and breadth.

TypeBroad incumbent
Description

Global testing services group with significant cell-based assay, safety, and biocompatibility testing offerings. Competes with acCELLerate for outsourced cell-based testing and reagents, especially with safety testing labs.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

acCELLerate

Biotech Reagentsaccellerate.me

acCELLerate firmographics

Firmographics
Name
acCELLerate
Legal name
acCELLerate GmbH
Website
https://accellerate.me
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

acCELLerate industry classification

Industry
Product category
Biotech Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAFAJ
In Vitro Toxicology (Cell-based/Organ-on-chip)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAAABAK
Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)

Keywords

  • Assay ready cells
  • Custom cell banking
  • In vitro bioassays
  • GMP potency assays
  • Cryopreserved cell reagents

Where acCELLerate is headquartered

Location

Headquarters

HQ city
Hamburg
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

acCELLerate business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Custom Cell Banking Services: Custom cell banking projects including Master Cell Banks (MCB), Working Cell Banks (WCB), and assay-ready instaCELLs. Projects include cell line transfer, cultivation and freezing process implementation, and preparation of starting cell banks. Batch sizes range from 50 to 1,000 vials with custom aliquots from 1 million to 100 million cells.
  2. instaCELL Assay Kits: Pre-packaged kits combining assay-ready instaCELLs, plates, media, reagents, and controls with validated protocols. Includes cytotoxicity, skin sensitization, genotoxicity, pyrogen detection, and bioassay kits.
  3. Premium GMP Documentation Service: Comprehensive GMP-compliant documentation for analytical cell banks used in GMP-bioassays. Includes manufacturing batch records, quality reports with certificate of analysis (CoA), and certificate of conformity (CoC).
  4. Cell Storage Services: Custom storage for cell banks under properly controlled conditions with on-demand delivery and automatic replenishment of assay-ready instaCELLs.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom cell banking projects are quote-based

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

acCELLerate product offering

Product offering

Core offering

acCELLerate produces and cryopreserves assay-ready cells (branded as instaCELLs) that can be used directly in cell-based assays without prior cultivation, functioning as consumable reagents. The company offers custom cell banking services (Master Cell Banks, Working Cell Banks, and large homogeneous assay-ready banks) for pharmaceutical and biotechnology clients, along with a portfolio of pre-validated assay kits for safety testing (cytotoxicity, skin sensitization, genotoxicity, pyrogen detection) and bioassay potency testing (TNF-α, G-CSF, GM-CSF, IL-2). It also supplies recombinant Assay Ready Cells (ARC) from partner AssayWorks for compound screening and lead identification.

Product overview

acCELLerate offers a portfolio of assay-ready cell products and custom cell banking services centered around their proprietary instaCELL technology. The core offering includes a comprehensive range of validated assay kits for safety testing (cytotoxicity, genotoxicity, skin sensitization, pyrogen detection) and bioassay potency testing (TNF-alpha, G-CSF, GM-CSF, IL-2), all featuring ready-to-use frozen cells that eliminate cell culture variability. Custom cell banking services provide Master Cell Banks (MCB), Working Cell Banks (WCB), and large homogeneous banks of assay-ready instaCELLs for pharmaceutical and biotechnology research. The ARC (Assay Ready Cells) line offers recombinant cell lines expressing receptors and ion channels for drug discovery screening applications. The company pioneered the assay-ready approach in Europe in the early 2000s and works with over 1,500 different cell lines.

Differentiator

Problem solved

Functional benefit

Brands

  • instaCELL: Assay-ready frozen cells that can be used directly in assays without prior cultivation, essentially functioning as a reagent. Available in kit format for various testing applications including cytotoxicity, biocompatibility, skin sensitization, genotoxicity, and pyrogen detection.

Products and services

  • instaCELL Cytotoxicity Assay Kit

Quantifiable outcome

  • Improved assay precision through exclusion of cell culture variability

Companies that use acCELLerate

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

acCELLerate technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

acCELLerate partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • ATCCcoreStrategic or Co-development Partner · 10 November 2025acCELLerate has established a partnership with ATCC to produce custom cell banks from ATCC's authenticated cell lines for research clients in pharmaceutical and biotechnology sectors. The collaboration aims to enhance assay reproducibility and scalability for research and development of new pharmaceuticals.
  • AssayWorkscoreTechnology or IntegrationAssayWorks, Germany developed recombinant cell lines expressing pharmaceutically relevant receptors and ion channels. acCELLerate provides these cell lines in assay ready format for compound screening, lead identification, and selectivity testing.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

acCELLerate competitors and assessment

Company assessment

Direct peers

  • ATCC (American Type Culture Collection): Global biological resource provider offering authenticated cell lines and related services. Direct comparable in cell-line supply and custom cell banking, and is also a strategic partner of acCELLerate for authenticated lines.
  • Cellular Technology Limited (CTL): Specializes in cryopreserved PBMCs and immune cell-based assay services (ELISpot, FluoroSpot). Comparable niche player focused on cryopreserved cells as reproducible assay inputs for immunology research.
  • PromoCell: German provider of primary human cells, cell culture media, and cell-based assays. Closely comparable to acCELLerate in geography, target customer (pharma/cosmetics/medical device testing labs), and product portfolio.
  • Cellero (BioLife Solutions): Supplies cryopreserved primary immune cells (PBMCs, NK cells, T cells) and related products for cell-based assays and cell therapy research. Highly comparable use case: turning cryopreserved cells into off-the-shelf assay reagents.

Broad incumbents

  • Bio-Techne: Supplies proteins, antibodies, and cell-based assay reagents including GMP-grade cytokines and cell culture tools. Overlaps with acCELLerate on the reagent side of potency and bioassay workflows.
  • Charles River Laboratories (HemaCare): Through HemaCare, supplies fresh and cryopreserved primary blood cells for research and cell therapy. Competes in the same cryopreserved-cell-for-assays market with the backing of a much larger CRO.
  • Sartorius (CellGenix): Through CellGenix, supplies GMP-grade raw materials and cell-based assay reagents for cell and gene therapy manufacturing. Comparable in the GMP bioassay and ATMP/QC tooling space, though at much larger scale.
  • Thermo Fisher Scientific (Gibco): Through its Gibco brand, supplies cell culture media, primary cells, and cell lines used in bioassays. Competes with acCELLerate across cell-based reagents and custom cell services, with much broader catalog and global reach.
  • Lonza Group: Global cell and gene therapy CDMO with a large cell biology products portfolio. Overlaps with acCELLerate in custom cell banking and cell-based assay reagents, but at far greater scale and breadth.
  • Eurofins Scientific: Global testing services group with significant cell-based assay, safety, and biocompatibility testing offerings. Competes with acCELLerate for outsourced cell-based testing and reagents, especially with safety testing labs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

acCELLerate social profiles

Digital presence

acCELLerate compliance and trust

Trust signal

Compliance1 record

acCELLerate financial estimates

Financial estimate

Revenue estimate

Valuation estimate

acCELLerate leadership team

Management profile

Number of profiles

Profiles8 records

acCELLerate funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

acCELLerate M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about acCELLerate

What does acCELLerate do?

acCELLerate produces and cryopreserves assay-ready cells (branded as instaCELLs) that can be used directly in cell-based assays without prior cultivation, functioning as consumable reagents. The company offers custom cell banking services (Master Cell Banks, Working Cell Banks, and large homogeneous assay-ready banks) for pharmaceutical and biotechnology clients, along with a portfolio of pre-validated assay kits for safety testing (cytotoxicity, skin sensitization, genotoxicity, pyrogen detection) and bioassay potency testing (TNF-α, G-CSF, GM-CSF, IL-2). It also supplies recombinant Assay Ready Cells (ARC) from partner AssayWorks for compound screening and lead identification.

Is acCELLerate a public or private company?

acCELLerate is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was acCELLerate founded?

acCELLerate was founded in 2000. It employs 11 to 50 people.

Where is acCELLerate based?

acCELLerate is headquartered in Hamburg, Germany, in the Europe region.

How does acCELLerate make money?

Four revenue lines are on record. Custom Cell Banking Services are the primary driver. The others are instaCELL Assay Kits, premium GMP Documentation Service and cell Storage Services.

Who are acCELLerate's main competitors?

Direct peers on record are ATCC (American Type Culture Collection), Cellular Technology Limited (CTL), PromoCell and Cellero (BioLife Solutions). Broad incumbents are Bio-Techne, Charles River Laboratories (HemaCare), Sartorius (CellGenix), Thermo Fisher Scientific (Gibco), Lonza Group and Eurofins Scientific.

Does acCELLerate have an API?

No public API is recorded for acCELLerate.

What industry is acCELLerate in?

acCELLerate's product category is Biotech Reagents. Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays), with a secondary code of HLAGAFAJ, In Vitro Toxicology (Cell-based/Organ-on-chip). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals